1

LE FOLL, B. et al. Tobacco and nicotine use. Nature Reviews Disease Primers, v. 8, n. 1, p. 19, 24 mar. 2022.

DOI: https://doi.org/10.1038/s41572-022-00346-w

2

PICHON-RIVIERE, A. et al. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study. The Lancet Global Health, v. 8, n. 10, p. e1282–e1294, out. 2020.

DOI: https://doi.org/10.1016/S2214-109X(20)30311-9

3

FATUMO, S. et al. A roadmap to increase diversity in genomic studies. Nature Medicine, v. 28, n. 2, p. 243–250, fev. 2022.

DOI: https://doi.org/10.1038/s41591-021-01672-4

4

SIRUGO, G.; WILLIAMS, S. M.; TISHKOFF, S. A. The Missing Diversity in Human Genetic Studies. Cell, v. 177, n. 1, p. 26–31, mar. 2019.

DOI: https://doi.org/10.1016/j.cell.2019.02.048

5

PRIVÉ, F. et al. Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort. The American Journal of Human Genetics, v. 109, n. 1, p. 12–23, jan. 2022.

DOI: https://doi.org/10.1016/j.ajhg.2021.11.008

6

MARTIN, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nature Genetics, v. 51, n. 4, p. 584–591, abr. 2019.

DOI: https://doi.org/10.1038/s41588-019-0379-x

7

SAUNDERS, G. R. B. et al. Genetic diversity fuels gene discovery for tobacco and alcohol use. Nature, v. 612, n. 7941, p. 720–724, 22 dez. 2022.